JI

Joshua Ismin

Limited Partner at Possible Ventures

Sydney, New South Wales

Overview

Work Experience

  • Co-founder, CEO

    2021 - Current

    Psylo (SMW21) is a small molecule biotech start-up developing next-generation therapeutics inspired by psychedelic compounds that exist in nature.  Psylo is targeting the 5-HT2A receptor for the treatment of neuropsychiatric conditions based on the emerging promise of psilocybin.  Our mission is to produce novel take-home medications which extend the healing potential of psychedelics to a broader patient population.

  • Limited Partner

    2022

  • Limited Partner

    2021

  • Limited Partner

    2016

  • Angel Investor

    2015

    Various angel investments such as Kanna Health, Finless Foods, Fable Foods, Stockheld Dreamery, Pana Travel (acquired), and Clarus Power.

  • Limited Partner

    2019

  • Limited Partner

    2018

  • Founder

    2018 - 2022

    OutBranch partners with digital media businesses to launch operations in APAC. Past projects include Tubi, SpokenLayer, and Emodo.

  • Vice President

    2015 - 2017

    After TVN was acquired we grew revenue by 4x, and launched two new APAC offices, including our New Zealand office (which had me based in Auckland for a year).

  • Co-Founder

    2010 - 2015

    Internet video business backed by Netus in 2010. Acquired by Tremor Video (now Magnite) as a launchpad for APAC growth.

Relevant Websites